Abstract: Individuals with fibromuscular dysplasia (FMD) have a higher risk of developing cerebral aneurysms. When this subgroup of patients presents with aneurysmal subarachnoid hemorrhage, management of cerebral vasospasm can be particularly challenging, both because they may be more susceptible to developing refractory vasospasm and also because they are at a higher risk for extracranial vascular injury from treatment. A female with Hunt-Hess Grade-1, Fisher Grade-2 subarachnoid hemorrhage from a ruptured left supraclinoid internal carotid artery (ICA) aneurysm was incidentally diagnosed with FMD during angiography for endovascular treatment of the aneurysm. She developed severe cerebral vasospasm refractory to aggressive medical and endovascular therapy. Early during the course of her treatment, she developed a symptomatic ICA dissection with multiple small dissecting aneurysms from hypertensive therapy, requiring stent placement. During our management of this patient, a literature review demonstrated limited information regarding management strategies for these patients. Therefore, with this article we intend to convey our experience with potential complications from subarachnoid hemorrhage management in this subgroup of patients and to review the available literature regarding this topic.
INTRODUCTION
Fibromuscular dysplasia (FMD) is an idiopathic, segmental, non-atherosclerotic arteriopathy that generally affects small-to-medium sized arteries such as the renal and cervical carotid arteries, but may also involve other arteries such as the vertebrals [1, 2] . The weakened arterial walls in FMD patients predispose them to spontaneous dissections [3] [4] [5] , intracranial aneurysms, and carotid-cavernous fistulae [6] [7] [8] . Arterial dissection can result in focal neurological deficits from either a thromboembolic event or hemodynamic compromise due to exposure of the inner arterial wall layers to the bloodstream or arterial lumen stenosis, respectively [9] . Intracranial aneurysms have 20-50% prevalence in patients with carotid or vertebral involvement suggesting a strong correlation between FMD and brain aneurysms [10] [11] [12] [13] . Additionally, there are reports of FMD patients presenting with aneurysmal subarachnoid hemorrhage (SAH), having a poor prognosis secondary to their susceptibility to cerebral vasospasm (CV) [11, 12] .
Here we present our case of a good grade SAH patient (Hunt-Hess Grade 1, Fisher Grade 2) with no history of FMD until diagnosed angiographically during aneurysm treatment. The patient had a complicated *Address correspondence to this author at the Department of Neurosurgery, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA; Tel: 1-315-464-5502; Fax: 1-315-464-6373; E-mail: deshaiee@upstate.edu hospital course due to unusually severe CV refractory to both medical and endovascular treatment [14] . The literature regarding the susceptibility of FMD patients to CV after SAH is limited so here, we are reporting our experience managing this patient and reviewing the available literature on this topic.
CASE REPORT

Clinical Presentation
A female (Hunt-Hess 1, Fisher Grade 2) in her 40s presented to the emergency room with the worst headache of her life that began four days prior to presentation. She had no significant past medical or family history, and was not on any medications. SAH was suspected and a brain CT/CTA confirmed the diagnosis of a left supraclinoid internal carotid artery (ICA) aneurysm without hydrocephalus and only a small amount of SAH located primarily in the left sylvian fissure. The patient was admitted for endovascular treatment of this aneurysm.
Neuroimaging Studies
Digital subtraction angiography (DSA) demonstrated a dysmorphic left supraclinoid ICA aneurysm (2.7 x 2.1 x 1.6 mm) with a dome/neck ratio of 2.2, and an aberrant middle cerebral artery (MCA) branch was arising from the side-wall of the internal carotid artery (ICA). Incidentally, a diagnosis of bilateral ICA (right worse than the left) and right vertebral artery (VA) FMD was made based upon angiographic findings ( Figure  1 ).
Endovascular Management
Given that she was post-bleed day (PBD) four and within the CV window, it was decided that endovascular rather than microsurgical treatment of the aneurysm would be preferred. The aneurysm was coiled with a single 2.6 mm x 6 cm Deltaplush coil (Codman & Shurtleff, Inc., Raynham MA, USA) (Figure 2) . Further coils could not be added because they were displacing the first coil during insertion and a stent would require her to be on antiplatelet agents in the setting of SAH when subsequent surgical interventions may be required, placing her at a high risk for bleeding After securing the aneurysm, the patient's systolic blood pressure (SBP) was liberalized up to 160 mmHg for hypertensive therapy for CV and she was watched closely in the neurosurgical intensive care unit. Six days later (PBD 10), she acutely developed aphasia with a dense right hemiparesis (strength grade 2/5). She was initially treated with standard hypertensive therapy bringing the SBP to 160-180 mmHg with some improvement. At this time, emergent DSA was performed demonstrating a right ICA dissection with multiple dissecting aneurysms (Figure 3) . Mild-tomoderate CV was also identified on the right ICA, MCA, ACA and moderate-to-severe CV in left ICA, MCA, ACA (Figure 4) ; the treated aneurysm remained occluded. The left ICA FMD changes remained stable compared to previous DSA. Intra-arterial treatment of the CV was performed with 30 mg verapamil in each ICA and the patient improved. No intervention was performed for right ICA dissection at this point because the stenosis was < 50% and again, antiplatelet agents were to be avoided in case she needed an external ventricular drain. The next day (PBD 11), she developed left sided weakness again and was taken back for DSA, this time demonstrating right ICA stenosis >50% from progression of the arterial dissection. At this point a right ICA Xpert (Abbott Laboratories, Abbott Park IL, USA) self expanding stent (6mm x 60mm) was placed and antiplatelet therapy was initiated (aspirin 325mg daily and plavix 75 mg daily). Recurrent moderate-to-severe left side and moderate right side CV were again treated with 30 mg verapamil in each ICA and her symptoms completely resolved.
Subsequently, she was taken for DSA the next day and she had moderate right sided, severe left sided and mild posterior circulation vasospasm. The CV showed minimal improvement after verapamil and nitroglycerine on the left side so ICA balloon angioplasty was performed with improvement in distal flow. The patient was then taken for pharmaceutical and mechanical spasmolytic therapy every twelve hours for three days. Mechanical spasmolysis was reserved for CV refractory to pharmaceutical spasmolysis because we were concerned that her FMD may further predispose her to arterial injury from angioplasty. During this period, she developed acute respiratory distress syndrome (ARDS) and cardiac output failure requiring multiple vasopressor agents. Her blood pressure no longer tolerated the intra-arterial boluses of spasmolytic agents so a microcatheter was left in the left cervical ICA for continuous intra-arterial verapamil infusion (0.1mg per minute) which she tolerated well from the blood pressure standpoint and improved her CV on CTA. Sepsis and endocrine (cortisol and thryroid function) work-up were normal. Multi-organ failure and cardiac arrest ensued and the family did not want to pursue further resuscitation; she succumbed to complications of SAH and FMD on the 15 th hospital day (PBD 19).
DISCUSSION
The first histological description of FMD was of the carotid artery in 1965 and a subsequent clinical report occurred in the neurosurgical literature in 1968 [15, 16] . FMD has traditionally been considered a benign disease and evoked little interest in the literature. Though the literature is sparse regarding the clinical management of FMD, the existing reports do describe the susceptibility of FMD patients to intracranial aneurysms, and ischemic or hemorrhagic stroke [10, [17] [18] [19] [20] .
In this case report, the authors want to address two major complications that occurred in this SAH patient, attributable to FMD: 1) cervical ICA dissection secondary to hypertensive therapy for CV, and 2) severe CV refractory to pharmaceutical and mechanical spasmolytic therapy.
Initial angiography of the right cervical ICA did not show any evidence of dissection or injury related to the angiogram. However, following hypertensive therapy for intracranial CV, she developed neurological deficits and an ICA dissection with multiple dissecting aneurysms and ipsilateral CV were identified on followup angiography. Initially it was unclear if the neurological deterioration was secondary to the dissection or CV. The dissection was not causing any apparent hemodynamic changes on angiography, we were trying to avoid antiplatelet agent use in case further surgical interventions were required during her treatment, and she improved after intra-arterial verapamil therapy for CV, therefore we held off on stenting the dissection and opted to follow it closely for worsening. Eventually the dissection did worsen and required stent placement and the initiation of antiplatelet agents.
Based on the initial angiography findings, the dissection most likely was secondary to the hemodynamic stress on the arterial wall from the hypertensive therapy as the ICA dissection was noticed on the common carotid artery angiogram (Figure 3) without the wire or the catheter entering into the ICA. Hemodynamic stress has been proposed as the potential cause of de novo dissecting aneurysms in FMD patients [11, 21] . Stehbens reported the association between hypertension and the development of intracranial aneurysms in this group of patients as well [22] . Spontaneous arterial dissections involving the cervical ICA and vertebral artery are more common with FMD and up to 15% of patients with cervical ICA dissection have FMD on imaging studies [3] [4] [5] 23] . Therefore, caution should be taken in patients with FMD who present with CV due to SAH, when initiating hypertensive therapy. Serial imaging of the carotid arteries with bedside duplex ultrasonography or other imaging modalities would help to detect ICA dissection. The onset of new neurological symptoms in these patients should not only raise the suspicion for CV, but also arterial dissection.
With regards to the second complication, the patient described in this report presented to a high volume aneurysm center with good Hunt-Hess and Fisher Grades, the latter making her risk of CV very low. Despite these low risks, she developed severe CV refractory to aggressive pharmaceutical and mechanical spasmolytic therapy. We judiciously used balloon angioplasty because of the concern that the FMD might make her more susceptible to arterial injury resulting in intracranial arterial rupture, dissection, or dissecting aneurysm formation, each of which would have further complicated her treatment course.
The correlation between FMD and CV has been reported in the past. In 1989, George et al. reported this correlation and demonstrated that FMD patients have worse clinical outcomes secondary to CV. They prospectively performed angiography on 87 patients and systematically investigated the cervical ICA and found FMD in 20 patients. In these cases, the female:male ratio was 5.6 with 50% of patients developing severe CV resulting in poor neurological outcomes [12] . In this report however, they did not assess whether the FMD patients had higher Fisher Grades than the non-FMD patients, making it difficult to draw any conclusions about risk of CV in SAH patients with FMD. Since that study, the association between FMD and CV has only been described in case reports [11, 24] . Though the association between FMD and CV has been previously reported, its limited awareness may be responsible for delaying the further elucidation of its mechanism.
In FMD patients presenting with SAH, we do recommend to consider microsurgical management of the aneurysm preferably over the endovascular option. Surgical interventions should be considered early in the course of management as these patients are more likely to develop arterial dissections during endovascular interventions requiring antiplatelet agents. Attempt should be made to keep the number of endovascular interventions to a minimum.
CONCLUSION
FMD patients are susceptible to cerebral aneurysm formation and extracranial arterial dissections and may be more prone to developing severe CV after SAH. Management of SAH and the treatment of CV can be complicated by the underlying vascular pathology, in FMD. Neurological deterioration should raise the suspicion not only for severe cerebral vasospasm but also arterial dissection. Astute clinical monitoring for the development of extracranial arterial dissections during hypertensive therapy with judicious stent placement for a hemodynamically significant arterial dissection is suggested. Lastly, in patients who do not tolerate intra-arterial boluses of antispasmolytic agents, low dose continuous infusion through a microcatheter left in the proximal extracranial artery, may be a safer and longer-lasting solution for treating severe cerebral vasospasm.
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